Singapore markets close in 4 hours 4 minutes

Global Medical REIT Inc. (GMRE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
8.40+0.07 (+0.84%)
At close: 04:00PM EDT
8.48 +0.08 (+0.95%)
After hours: 07:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 550.93M
Enterprise value 1.24B
Trailing P/E 36.52
Forward P/E 333.33
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.91
Price/book (mrq)1.08
Enterprise value/revenue 8.82
Enterprise value/EBITDA 11.14

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3-6.19%
S&P500 52-week change 322.38%
52-week high 311.59
52-week low 37.98
50-day moving average 38.59
200-day moving average 39.47

Share statistics

Avg vol (3-month) 3412.28k
Avg vol (10-day) 3410.12k
Shares outstanding 565.59M
Implied shares outstanding 62.54M
Float 861.79M
% held by insiders 15.76%
% held by institutions 158.84%
Shares short (15 Apr 2024) 41.32M
Short ratio (15 Apr 2024) 42.89
Short % of float (15 Apr 2024) 42.14%
Short % of shares outstanding (15 Apr 2024) 42.02%
Shares short (prior month 15 Mar 2024) 41.25M

Dividends & splits

Forward annual dividend rate 40.84
Forward annual dividend yield 410.00%
Trailing annual dividend rate 30.21
Trailing annual dividend yield 32.52%
5-year average dividend yield 47.13
Payout ratio 4365.22%
Dividend date 309 Apr 2024
Ex-dividend date 421 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 14.61%
Operating margin (ttm)25.49%

Management effectiveness

Return on assets (ttm)1.78%
Return on equity (ttm)3.46%

Income statement

Revenue (ttm)141.05M
Revenue per share (ttm)2.15
Quarterly revenue growth (yoy)-9.20%
Gross profit (ttm)N/A
EBITDA 91.86M
Net income avi to common (ttm)14.79M
Diluted EPS (ttm)0.23
Quarterly earnings growth (yoy)-66.20%

Balance sheet

Total cash (mrq)26.4M
Total cash per share (mrq)0.4
Total debt (mrq)618.91M
Total debt/equity (mrq)102.16%
Current ratio (mrq)2.25
Book value per share (mrq)7.76

Cash flow statement

Operating cash flow (ttm)68.44M
Levered free cash flow (ttm)85.63M